Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Ellen Davies

Showing results (21-30 of 45) with videos related to

Pageof 5
Sort By:
Antimicrobial Agents and Chemotherapy|December 17, 2008
Robust antiviral efficacy upon administration of a nucleoside analog to hepatitis C virus-infected chimpanzeesSteven S Carroll, Steven Ludmerer, Larry Handt, et al.
Vaccine|May 13, 2008
Enhanced in vivo transgene expression and immunogenicity from plasmid vectors following electrostimulation in rodents and primatesAdam J Simon, Danilo R Casimiro, Adam C Finnefrock, et al.
Antimicrobial Agents and Chemotherapy|December 1, 2010
Sustained viral response in a hepatitis C virus-infected chimpanzee via a combination of direct-acting antiviral agentsDavid B Olsen, Mary-Ellen Davies, Larry Handt, et al.
Virology|January 16, 2007
Early depletion of proliferating B cells of germinal center in rapidly progressive simian immunodeficiency virus infectionZhi-Qiang Zhang, Danilo R Casimiro, William A Schleif, et al.
The Journal of Pharmacology and Experimental Therapeutics|April 1, 2004
DiPOA ([8-(3,3-diphenyl-propyl)-4-oxo-1-phenyl-1,3,8-triazaspiro[4.5]dec-3-yl]-acetic acid), a novel, systemically available, and peripherally restricted mu opioid agonist with antihyperalgesic activity: I. In vitro pharmacological characterization and pharmacokinetic propertiesKenneth J Valenzano, Wendy Miller, Zhengming Chen, et al.
Journal of Virology|September 5, 2002
Sustained peptide-specific gamma interferon T-cell response in rhesus macaques immunized with human immunodeficiency virus gag DNA vaccinesMichael J Caulfield, Su Wang, Jeffrey G Smith, et al.
Journal of Virology|September 29, 2004
Heterologous human immunodeficiency virus type 1 priming-boosting immunization strategies involving replication-defective adenovirus and poxvirus vaccine vectorsDanilo R Casimiro, Andrew J Bett, Tong-ming Fu, et al.
Journal of Virology|January 28, 2006
A novel adenovirus type 6 (Ad6)-based hepatitis C virus vector that overcomes preexisting anti-ad5 immunity and induces potent and broad cellular immune responses in rhesus macaquesStefania Capone, Annalisa Meola, Bruno Bruni Ercole, et al.
Journal of Immunology (Baltimore, Md. : 1950)|January 5, 2002
Potent CD4+ T cell responses elicited by a bicistronic HIV-1 DNA vaccine expressing gp120 and GM-CSFDan H Barouch, Sampa Santra, Klara Tenner-Racz, et al.
Virology|September 17, 2008
The effect of early versus delayed challenge after vaccination in controlling SHIV 89.6P infectionLeslie L Chavez, Miles P Davenport, John W Shiver, et al.
Pageof 5

Showing results (21-30 of 45) with videos related to

Sort By:
Pageof 5
Antimicrobial Agents and Chemotherapy|December 17, 2008
Robust antiviral efficacy upon administration of a nucleoside analog to hepatitis C virus-infected chimpanzeesSteven S Carroll, Steven Ludmerer, Larry Handt, et al.
Vaccine|May 13, 2008
Enhanced in vivo transgene expression and immunogenicity from plasmid vectors following electrostimulation in rodents and primatesAdam J Simon, Danilo R Casimiro, Adam C Finnefrock, et al.
Antimicrobial Agents and Chemotherapy|December 1, 2010
Sustained viral response in a hepatitis C virus-infected chimpanzee via a combination of direct-acting antiviral agentsDavid B Olsen, Mary-Ellen Davies, Larry Handt, et al.
Virology|January 16, 2007
Early depletion of proliferating B cells of germinal center in rapidly progressive simian immunodeficiency virus infectionZhi-Qiang Zhang, Danilo R Casimiro, William A Schleif, et al.
The Journal of Pharmacology and Experimental Therapeutics|April 1, 2004
DiPOA ([8-(3,3-diphenyl-propyl)-4-oxo-1-phenyl-1,3,8-triazaspiro[4.5]dec-3-yl]-acetic acid), a novel, systemically available, and peripherally restricted mu opioid agonist with antihyperalgesic activity: I. In vitro pharmacological characterization and pharmacokinetic propertiesKenneth J Valenzano, Wendy Miller, Zhengming Chen, et al.
Journal of Virology|September 5, 2002
Sustained peptide-specific gamma interferon T-cell response in rhesus macaques immunized with human immunodeficiency virus gag DNA vaccinesMichael J Caulfield, Su Wang, Jeffrey G Smith, et al.
Journal of Virology|September 29, 2004
Heterologous human immunodeficiency virus type 1 priming-boosting immunization strategies involving replication-defective adenovirus and poxvirus vaccine vectorsDanilo R Casimiro, Andrew J Bett, Tong-ming Fu, et al.
Journal of Virology|January 28, 2006
A novel adenovirus type 6 (Ad6)-based hepatitis C virus vector that overcomes preexisting anti-ad5 immunity and induces potent and broad cellular immune responses in rhesus macaquesStefania Capone, Annalisa Meola, Bruno Bruni Ercole, et al.
Journal of Immunology (Baltimore, Md. : 1950)|January 5, 2002
Potent CD4+ T cell responses elicited by a bicistronic HIV-1 DNA vaccine expressing gp120 and GM-CSFDan H Barouch, Sampa Santra, Klara Tenner-Racz, et al.
Virology|September 17, 2008
The effect of early versus delayed challenge after vaccination in controlling SHIV 89.6P infectionLeslie L Chavez, Miles P Davenport, John W Shiver, et al.
Pageof 5